These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37993376)

  • 1. Non-alcoholic fatty liver disease and periodontal disease: A systematic review and meta-analysis of cross-sectional studies.
    Aguiar ILS; Santos-Lins LS; Brasil-Oliveira R; Cotrim HP; Lins-Kusterer L
    Arab J Gastroenterol; 2023 Nov; 24(4):198-203. PubMed ID: 37993376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periodontal disease-related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: An emerging concept of oral-liver axis.
    Kuraji R; Sekino S; Kapila Y; Numabe Y
    Periodontol 2000; 2021 Oct; 87(1):204-240. PubMed ID: 34463983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis.
    Quek J; Chan KE; Wong ZY; Tan C; Tan B; Lim WH; Tan DJH; Tang ASP; Tay P; Xiao J; Yong JN; Zeng RW; Chew NWS; Nah B; Kulkarni A; Siddiqui MS; Dan YY; Wong VW; Sanyal AJ; Noureddin M; Muthiah M; Ng CH
    Lancet Gastroenterol Hepatol; 2023 Jan; 8(1):20-30. PubMed ID: 36400097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periodontal disease could be a potential risk factor for non-alcoholic fatty liver disease: An 11-year retrospective follow-up study.
    Shin HS; Hong MH; Moon JY; Sim SJ
    Clin Oral Investig; 2022 Aug; 26(8):5503-5514. PubMed ID: 35556175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis: HCC and Steatosis or Steatohepatitis.
    Petrelli F; Manara M; Colombo S; De Santi G; Ghidini M; Mariani M; Iaculli A; Rausa E; Rampulla V; Arru M; Viti M; Lonati V; Ghidini A; Luciani A; Facciorusso A
    Neoplasia; 2022 Aug; 30():100809. PubMed ID: 35636146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between periodontal disease, tooth loss and liver diseases risk.
    Chen Y; Yang YC; Zhu BL; Wu CC; Lin RF; Zhang X
    J Clin Periodontol; 2020 Sep; 47(9):1053-1063. PubMed ID: 32621350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis-A Systematic Review, Meta-Analysis and Meta-Regression.
    Gudan A; Jamioł-Milc D; Hawryłkowicz V; Skonieczna-Żydecka K; Stachowska E
    Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is There An Association Between Periodontitis And Non-Alcoholic Fatty Liver Disease? A Systematic Review and Meta-Analysis.
    Xu F; Tang J
    Community Dent Health; 2023 Feb; 40(1):47-52. PubMed ID: 36696480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bidirectional association between non-alcoholic fatty liver disease and fatty pancreas: a systematic review and meta-analysis.
    Wongtrakul W; Untaaveesup S; Pausawadi N; Charatcharoenwitthaya P
    Eur J Gastroenterol Hepatol; 2023 Oct; 35(10):1107-1116. PubMed ID: 37665612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between NAFLD and Periodontal Disease from the View of Clinical and Basic Research, and Immunological Response.
    Hatasa M; Yoshida S; Takahashi H; Tanaka K; Kubotsu Y; Ohsugi Y; Katagiri T; Iwata T; Katagiri S
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High risk of colorectal polyps in men with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Chen W; Wang M; Jing X; Wu C; Zeng Y; Peng J; Cai X
    J Gastroenterol Hepatol; 2020 Dec; 35(12):2051-2065. PubMed ID: 32579269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients.
    Huang Y; Gan Q; Lai R; Wang W; Guo S; Sheng Z; Chen L; Guo Q; Cai W; Wang H; Zhao G; Cao Z; Xie Q
    Front Cell Infect Microbiol; 2021; 11():733348. PubMed ID: 35111690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies.
    Jarvis H; Craig D; Barker R; Spiers G; Stow D; Anstee QM; Hanratty B
    PLoS Med; 2020 Apr; 17(4):e1003100. PubMed ID: 32353039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.
    Ye Q; Zou B; Yeo YH; Li J; Huang DQ; Wu Y; Yang H; Liu C; Kam LY; Tan XXE; Chien N; Trinh S; Henry L; Stave CD; Hosaka T; Cheung RC; Nguyen MH
    Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):739-752. PubMed ID: 32413340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet therapy associated with lower prevalence of advanced liver fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Thongtan T; Deb A; Vutthikraivit W; Laoveeravat P; Mingbunjerdsuk T; Islam S; Islam E
    Indian J Gastroenterol; 2022 Apr; 41(2):119-126. PubMed ID: 35318571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis.
    Musso G; Gambino R; Tabibian JH; Ekstedt M; Kechagias S; Hamaguchi M; Hultcrantz R; Hagström H; Yoon SK; Charatcharoenwitthaya P; George J; Barrera F; Hafliðadóttir S; Björnsson ES; Armstrong MJ; Hopkins LJ; Gao X; Francque S; Verrijken A; Yilmaz Y; Lindor KD; Charlton M; Haring R; Lerch MM; Rettig R; Völzke H; Ryu S; Li G; Wong LL; Machado M; Cortez-Pinto H; Yasui K; Cassader M
    PLoS Med; 2014 Jul; 11(7):e1001680. PubMed ID: 25050550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease.
    Yoneda M; Naka S; Nakano K; Wada K; Endo H; Mawatari H; Imajo K; Nomura R; Hokamura K; Ono M; Murata S; Tohnai I; Sumida Y; Shima T; Kuboniwa M; Umemura K; Kamisaki Y; Amano A; Okanoue T; Ooshima T; Nakajima A
    BMC Gastroenterol; 2012 Feb; 12():16. PubMed ID: 22340817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis.
    Mantovani A; Dauriz M; Byrne CD; Lonardo A; Zoppini G; Bonora E; Targher G
    Metabolism; 2018 Oct; 87():1-12. PubMed ID: 29935236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cross-sectional study assessing the relationship between non-alcoholic fatty liver disease and periodontal disease.
    Sato S; Kamata Y; Kessoku T; Shimizu T; Kobayashi T; Kurihashi T; Takashiba S; Hatanaka K; Hamada N; Kodama T; Higurashi T; Taguri M; Yoneda M; Usuda H; Wada K; Nakajima A; Morozumi T; Minabe M
    Sci Rep; 2022 Aug; 12(1):13621. PubMed ID: 35948584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential association between periodontitis and non-alcoholic fatty liver disease: a systematic review.
    Alakhali MS; Al-Maweri SA; Al-Shamiri HM; Al-Haddad K; Halboub E
    Clin Oral Investig; 2018 Dec; 22(9):2965-2974. PubMed ID: 30357481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.